Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial

Full text for this resource is not available from the Research Repository.

Herbert, K, Demosthenous, L, Wiesner, Glen ORCID: 0000-0002-0071-130X, Link, E, Westerman, D, Came, N, Ritchie, D, Harrison, S, Seymour, JF and Prince, H (2014) Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trial. Bone Marrow Transplantation, 49. 1056 - 1062. ISSN 0268-3369

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/35255
DOI https://doi.org/10.1038/bmt.2014.112
Official URL https://www.nature.com/articles/bmt2014112
Subjects Historical > FOR Classification > 1103 Clinical Sciences
Historical > FOR Classification > 1107 Immunology
Current > Division/Research > College of Sports and Exercise Science
Keywords mobilisation; mobilisers; bone marrow transplants; immunostimulants; blood
Citations in Scopus 10 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login